Clinical trial
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of…
NCT00468910 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00468910 |
|---|---|
| Title | Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer |
| Official title | Spectral Markers in Aspirin Chemoprevention of Colonic Neoplasia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer, Precancerous Condition, Rectal Cancer |
| Intervention type | Drug, Other |
| Interventions | acetylsalicylic acid, placebo, laboratory biomarker analysis |
| Enrollment | 79 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Aug 1, 2011 |
| First posted | May 3, 2007 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: